Close the combination of Mylan and Pfizer's Upjohn business
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 30 Oct 2020
- Due
- 16 Nov 2020
- Delivered
- 16 Nov 2020
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The combination is expected to close on November 16, 2020”
What we found
Evidence strength A What the grades mean
Pfizer confirmed in multiple SEC filings that the spin-off and combination of its Upjohn business with Mylan to form Viatris was completed on November 16, 2020.
-
A Pfizer Inc. 10-K filed 2021-02-25
“following the November 16, 2020 spin-off and combination of the Upjohn Business with Mylan” ✓ confirmed on the page
-
A Pfizer Inc. 10-Q filed 2021-05-13
“On November 16, 2020, we completed the spin-off and the combination of our Upjohn Business with Mylan to form Viatris.” ✓ confirmed on the page
Market reaction: the shares moved +0.4% against the S&P 500 over the three sessions around the disclosure (24 Feb 2021 to 1 Mar 2021). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Transaction other
- Indicative materiality
- Medium rules
- Action
- Close
- Deliverable
- Combination of Mylan and Upjohn
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Conditional
- Yes: satisfaction of other customary closing conditions
- Depends on
- Partner
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Pfizer Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-PFE-003844 · Corrections policy